IPO listed on 30 Oct'24
Godavari Biorefineries Ltd
Minimum Investment
₹ 14,784 / 42 shares
Grey market premium
₹ 5 (1% premium)
Issue price
₹ 352
Listing price
₹ 308
Listing gains
-44 (-13%)
Listing on
Oct 30, 2024
Our Verdict:
Avoid
- Godavari Biorefineries Ltd (GBL) has shown fluctuating performance in its financial indicators. While FY23 experienced growth in revenue and profits, FY24 witnessed a slowdown and with a notable loss recorded in Q1 of FY25. Further, its profit margins have consistently deteriorated in the recent years.
- The IPO is aggressively priced, with a price-to-earnings (P/E) ratio of 120x based on FY24 earnings, raising concerns about its valuation.
- Although the company could benefit from the recent easing of ethanol production norms, the high IPO valuation is not justified due to significant risks, including a substantial debt burden, despite optimism about future performance.
- Considering these aspects, long-term investors should keep this stock on radar and monitor the firm’s performance for the next two quarters before investing, as the inherent risks currently outweigh the potential benefits.
About the company
Founded in
12 Jan'56
Managing director
Samir Somaiya
- GBL is an integrated bio-refinery in India with a production capacity of 570 KLPD for ethanol as of June 30, 2024. It produces ethanol-based chemicals and offers a diverse product portfolio, including bio-based chemicals, sugar, various grades of ethanol, and power. These products serve industries such as food, beverages, pharmaceuticals, flavors and fragrances, power, fuel, personal care, and cosmetics.
- GBL uses sugarcane as its primary feedstock to produce a wide range of products, including sugar, ethanol, bio-based chemicals, and power. It was among the first companies in India to use sugarcane juice and syrup for ethanol production.
STRENGTHS
- Market Leadership: As of March 31, 2024, GBL stands as one of India's leading ethanol producers by volume. It holds the distinction of being the largest global manufacturer of MPO (3-Methyl-3-penten-2-one), one of only two producers of natural 1,3 butylene glycol, and the sole manufacturer of bio ethyl acetate in India.
- Marquee Clientele: GBL serves prominent clients including Hershey India Pvt Ltd, Hindustan Coca-Cola Beverages Pvt Ltd, Karnataka Chemical Industries, Escorts Chemical Industries, along with major oil marketing companies.
RISK FACTORS
- Deteriorating Financials: GBL observed a downturn in both revenue and profit in FY24, notably recording a loss in Q1 of FY25. This downturn is linked to the Government of India's sudden prohibition on ethanol blending.
- Declining Margin & Returns: Over the past three years, the net profit margin declined from 1.12% in FY22 to 0.72% in FY24. Similarly, Return on Equity and Return on Capital Employed decreased from 8.21% to 4.73% and from 10.64% to 9.53%, respectively.
- High Debt Levels: As of June 30, 2024, GBL reported a total consolidated debt of Rs 748.88 crore, with a Debt-to-Equity ratio of 3.01x.
- Supplier Dependency: GBL relies heavily on a limited number of suppliers for a substantial portion of its raw materials (excluding sugarcane), with the top 3, 5, and 10 suppliers accounting for 68.94%, 84.10%, and 94.71% of raw material purchases, respectively, as of FY24. Disruptions in these supplies could negatively affect its manufacturing and operational results.
- Client Concentration: In FY24, GBL generated approximately 57% of its revenue from its top 10 clients. The loss of a key client or multiple clients could significantly impact its financial performance.
- Cash Flow Concerns: GBL experienced negative cash flows from operations during the quarter ending June 30, 2024. If this trend continues, it could undermine the firm’s operational efficiency and financial health.
- Legal Risks: GBL is involved in ongoing legal disputes related to its promoters and directors. Unfavourable outcomes in these cases could harm the company's reputation and financial stability.
Issue details
Issue type
Mainstream
Issue size
₹ 554.75 crore
Fresh Issue
₹ 325 crore
OFS
₹ 229.75 crore
Price range
₹ 334 - 352
Lot size
42 shares
Issue Objective
GBL intends to use the net proceeds from the issue for the following purposes:
- Repayment/pre-payment of certain outstanding borrowings; and
- General corporate purposes.
Dates
Bidding open
23 Oct'24
Bidding close
25 Oct'24
Allotment date
28 Oct'24
Refund date
29 Oct'24
Listing
30 Oct'24
IPO Reservations
Qualified institutional buyers
<50%
Non-institutional investors
>15%
Retail individual investors
>35%
Read the Offer Document
© 2025 by Liquide Solutions Private Limited, SEBI Registered Research Analyst (Registration number - INH000009816)
This document has been issued by Liquide Solutions Private Limited for information purposes only. It does not have regard to specific investment objectives, financial situation and the particular needs of any specific person who may receive this document. Investors should seek personal and independent advice regarding the appropriateness of investing in any of the funds, securities, other investment or investment strategies that may have been discussed or referred herein and should understand that the views regarding future prospects may or may not be realized. In no event shall Liquide Life Private Limited and / or its affiliates or any of their directors, trustees, officers and employees be liable for any direct, indirect, special, incidental or consequential damages arising out of the use of information / opinion herein.